These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 36653846)

  • 1. The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome.
    Rasa-Dzelzkaleja S; Krumina A; Capenko S; Nora-Krukle Z; Gravelsina S; Vilmane A; Ievina L; Shoenfeld Y; Murovska M;
    J Transl Med; 2023 Jan; 21(1):33. PubMed ID: 36653846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
    Gravelsina S; Vilmane A; Svirskis S; Rasa-Dzelzkaleja S; Nora-Krukle Z; Vecvagare K; Krumina A; Leineman I; Shoenfeld Y; Murovska M
    Front Immunol; 2022; 13():928945. PubMed ID: 36300129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome.
    Shikova E; Reshkova V; Kumanova А; Raleva S; Alexandrova D; Capo N; Murovska M; On Behalf Of The European Network On Me/Cfs Euromene
    J Med Virol; 2020 Dec; 92(12):3682-3688. PubMed ID: 32129496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs Expression in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Soffritti I; Gravelsina S; D'Accolti M; Bini F; Mazziga E; Vilmane A; Rasa-Dzelzkaleja S; Nora-Krukle Z; Krumina A; Murovska M; Caselli E
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
    Front Immunol; 2019; 10():1946. PubMed ID: 31475007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Chapenko S; Krumina A; Logina I; Rasa S; Chistjakovs M; Sultanova A; Viksna L; Murovska M
    Adv Virol; 2012; 2012():205085. PubMed ID: 22927850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lee JS; Lacerda EM; Nacul L; Kingdon CC; Norris J; O'Boyle S; Roberts CH; Palla L; Riley EM; Cliff JM
    Front Med (Lausanne); 2021; 8():656692. PubMed ID: 34422848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities.
    Cox BS; Alharshawi K; Mena-Palomo I; Lafuse WP; Ariza ME
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35482424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M; Twisk FN; Kubera M; Ringel K
    J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
    Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of viral infection as an etiology of ME/CFS: a systematic review and meta-analysis.
    Hwang JH; Lee JS; Oh HM; Lee EJ; Lim EJ; Son CG
    J Transl Med; 2023 Oct; 21(1):763. PubMed ID: 37898798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
    Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
    Front Immunol; 2022; 13():949787. PubMed ID: 36341457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis.
    Kerr JR; Gough J; Richards SC; Main J; Enlander D; McCreary M; Komaroff AL; Chia JK
    J Gen Virol; 2010 Apr; 91(Pt 4):893-7. PubMed ID: 20007355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Schreiner P; Harrer T; Scheibenbogen C; Lamer S; Schlosser A; Naviaux RK; Prusty BK
    Immunohorizons; 2020 Apr; 4(4):201-215. PubMed ID: 32327453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
    Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M; Twisk FN; Johnson C
    Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.